Cargando…
Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?
Since its identification, much information has been obtained about prostate-specific antigen (PSA, or human glandular kallikrein 3 [hK3]), a kallikrein-like serine protease that is the most valuable tumour marker for the screening, diagnosis and management of human prostate carcinoma. Recently, it h...
Autores principales: | Mannello, Ferdinando, Gazzanelli, Giancarlo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138688/ https://www.ncbi.nlm.nih.gov/pubmed/11434875 http://dx.doi.org/10.1186/bcr302 |
Ejemplares similares
-
Diagnostic performance of PCA3 and hK2 in combination with serum PSA for prostate cancer
por: Mao, Zujie, et al.
Publicado: (2018) -
Roles of kallikrein-2 biomarkers (free-hK2 and pro-hK2) for predicting prostate cancer progression-free survival
por: Guerrico, Anatilde Gonzalez, et al.
Publicado: (2017) -
Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
por: Nilsson, O., et al.
Publicado: (1997) -
Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
por: Ragavan, N.
Publicado: (2014) -
Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma
por: Yin, Ming, et al.
Publicado: (2007)